- Home
- KLRS vs GPRO Comparison
KLRS vs GPRO Comparison
Compare KLRS & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- GPRO
- Stock Information
- Founded
- KLRS 2019
- GPRO 2004
- Country
- KLRS United States
- GPRO United States
- Employees
- KLRS N/A
- GPRO N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- GPRO Industrial Machinery/Components
- Sector
- KLRS Health Care
- GPRO Consumer Discretionary
- Exchange
- KLRS Nasdaq
- GPRO Nasdaq
- Market Cap
- KLRS 129.0M
- GPRO 118.4M
- IPO Year
- KLRS N/A
- GPRO 2014
- Fundamental
- Price
- KLRS $2.69
- GPRO $1.20
- Analyst Decision
- KLRS Buy
- GPRO Hold
- Analyst Count
- KLRS 1
- GPRO 1
- Target Price
- KLRS N/A
- GPRO $1.50
- AVG Volume (30 Days)
- KLRS 57.0K
- GPRO 20.3M
- Earning Date
- KLRS 08-15-2025
- GPRO 08-11-2025
- Dividend Yield
- KLRS N/A
- GPRO N/A
- EPS Growth
- KLRS N/A
- GPRO N/A
- EPS
- KLRS N/A
- GPRO N/A
- Revenue
- KLRS N/A
- GPRO $780,312,000.00
- Revenue This Year
- KLRS N/A
- GPRO N/A
- Revenue Next Year
- KLRS N/A
- GPRO $6.79
- P/E Ratio
- KLRS N/A
- GPRO N/A
- Revenue Growth
- KLRS N/A
- GPRO N/A
- 52 Week Low
- KLRS $2.28
- GPRO $0.40
- 52 Week High
- KLRS $24.15
- GPRO $2.37
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- GPRO 56.88
- Support Level
- KLRS N/A
- GPRO $1.23
- Resistance Level
- KLRS N/A
- GPRO $1.44
- Average True Range (ATR)
- KLRS 0.00
- GPRO 0.22
- MACD
- KLRS 0.00
- GPRO 0.01
- Stochastic Oscillator
- KLRS 0.00
- GPRO 27.78
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.